<p>ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer types in petri dishes and animal models by targeting a […]</p>
Share This Story
<p>In recognition of the U.S. News and World Report’s Best Grad Schools for 2023 rankings, large banners were erected to showcase the Long School of Medicine’s achievement of being named a top 50 medical school for the second year in a row. The banners are located on the facade of the parking garage near the Long School of Medicine on the Long Campus.</p>
Share This Story
<p>Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have discovered how Vitamin B12 (VB12) can play an integral role in the regulation of host intestinal homeostasis, shaping the gut microbiome health and protecting against pathogenic infections, as found in mouse models. The study, published June 8 in […]</p>
Share This Story
<p>Ruth Serrano, MD, a physician-scientist and assistant professor in the Division of Infectious Disease in the Department of Medicine in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has a passion and drive to help her patients recover from the profound effects of infectious diseases, including HIV and […]</p>
Share This Story
<p>This year’s Voelcker Fund Young Investigator Award recipients at UT Health San Antonio are Crystal Archer, PhD, Masahiro Morita, PhD, Neelam Mukherjee, PhD, and Angelina Vaseva, PhD.</p>
Share This Story
<p>An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions. </p>
Share This Story
<p>In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.</p>
Share This Story
<p>Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center at UT Health San Antonio, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The hearing was titled “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight.” Dr. Mesa […]</p>
Share This Story
<p>UT Health San Antonio is receiving $10.9 million in new research and faculty recruitment awards announced Feb. 16 by the Cancer Prevention and Research Institute of Texas (CPRIT). The statewide cancer agency has now awarded $128.7 million to UT Health San Antonio since 2010. A five-year, $6 million CPRIT Recruitment of Established Investigators award — […]</p>
Share This Story
<p>First lady Jill Biden toured Mays Cancer Center at UT Health San Antonio and praised its efforts in addressing disparities in cancer rates among Latinos.</p>
Share This Story